NHLRC2 and infection: Two patients with compound heterozygous NHLRC2 variants (patients five and seven) died because of progressive respiratory and multiorgan failure at the age of 10–11 months, whereas their siblings were alive, with current ages of 6 (patient six) and 19 years (patient four) and were relatively stable with fewer respiratory problems and infections since the age of 2.